These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 9272757
1. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635. Collinson N, Dawson GR. Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757 [Abstract] [Full Text] [Related]
2. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice. Briones-Aranda A, López-Rubalcava C, Picazo O. Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992 [Abstract] [Full Text] [Related]
3. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents. Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ. Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316 [Abstract] [Full Text] [Related]
4. Anxiolytic effects of prelimbic 5-HT(1A) receptor activation in the hemiparkinsonian rat. Hui YP, Wang T, Han LN, Li LB, Sun YN, Liu J, Qiao HF, Zhang QJ. Behav Brain Res; 2015 Jan 15; 277():211-20. PubMed ID: 24906197 [Abstract] [Full Text] [Related]
5. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Carli M, Samanin R. Psychopharmacology (Berl); 2000 Apr 15; 149(3):259-68. PubMed ID: 10823407 [Abstract] [Full Text] [Related]
6. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model. Cervo L, Mocaër E, Bertaglia A, Samanin R. Neuropharmacology; 2000 Apr 03; 39(6):1037-43. PubMed ID: 10727714 [Abstract] [Full Text] [Related]
7. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. de Boer SF, Lesourd M, Mocaer E, Koolhaas JM. J Pharmacol Exp Ther; 1999 Mar 03; 288(3):1125-33. PubMed ID: 10027850 [Abstract] [Full Text] [Related]
8. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR. Br J Pharmacol; 1990 Feb 03; 99(2):343-9. PubMed ID: 1970269 [Abstract] [Full Text] [Related]
9. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M. J Pharmacol Exp Ther; 1997 Jul 03; 282(1):148-61. PubMed ID: 9223550 [Abstract] [Full Text] [Related]
10. Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rats selectively bred for differences in 8-OH-DPAT-induced hypothermia. McQueen DA, Overstreet DH, Ardayfio PA, Commissaris RL. Behav Pharmacol; 2001 Nov 03; 12(6-7):509-16. PubMed ID: 11742145 [Abstract] [Full Text] [Related]
11. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze. Kõks S, Beljajev S, Koovit I, Abramov U, Bourin M, Vasar E. Psychopharmacology (Berl); 2001 Jan 03; 153(3):365-72. PubMed ID: 11271409 [Abstract] [Full Text] [Related]
12. Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression. Rhoads DE, Grimes N, Kaushal S, Mallari J, Orlando K. Pharmacol Biochem Behav; 2012 Jul 03; 102(1):58-63. PubMed ID: 22494991 [Abstract] [Full Text] [Related]
13. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. Braida D, Limonta V, Malabarba L, Zani A, Sala M. Eur J Pharmacol; 2007 Jan 26; 555(2-3):156-63. PubMed ID: 17116299 [Abstract] [Full Text] [Related]
14. Influence of light cycle on response to 5-HT1A ligands in punished responding in rats. Gleason SD, Leander JD. Behav Pharmacol; 1999 Dec 26; 10(8):785-91. PubMed ID: 10780294 [Abstract] [Full Text] [Related]
15. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats. Assié MB, Koek W. Eur J Pharmacol; 2000 Dec 08; 409(2):173-7. PubMed ID: 11104831 [Abstract] [Full Text] [Related]
17. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors. Otano A, García-Osta A, Ballaz S, Frechilla D, Del Río J. Br J Pharmacol; 1999 Dec 08; 128(8):1691-8. PubMed ID: 10588924 [Abstract] [Full Text] [Related]
18. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice. Gomes KS, Nunes-De-Souza RL. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct 01; 33(7):1261-9. PubMed ID: 19625008 [Abstract] [Full Text] [Related]
19. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Protais P, Lesourd M, Comoy E. Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353 [Abstract] [Full Text] [Related]
20. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats. Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E. J Pharm Pharmacol; 2003 Apr 10; 55(4):533-43. PubMed ID: 12803776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]